Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Moodys
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Patent: 10,184,001

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 10,184,001
Title:Effector-deficient anti-CD32a antibodies
Abstract: Effector-deficient anti-CD32a monoclonal antibodies are encompassed, as are method and uses for treating CD32a-mediated diseases and disorders, including, thrombocytopenia, allergy, hemostatic disorders, immune, inflammatory, and autoimmune disorders.
Inventor(s): Francis; John (Longwood, FL), Amirkhosravi; Ali (Longwood, FL), Meyer; Todd (Longwood, FL), Robles-Carrillo; Liza (Rockledge, FL)
Assignee: Adventist Health System/Sunbelt Inc. (Altamonte Springs, FL)
Application Number:15/171,734
Patent Claims:see list of patent claims

Details for Patent 10,184,001

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Janssen Biotech STELARA ustekinumab INJECTABLE;INJECTION 761044 001 2019-11-07   Start Trial Adventist Health System/Sunbelt Inc. (Altamonte Springs, FL) 2034-11-26 RX search
Janssen Biotech SIMPONI ARIA golimumab INJECTABLE; INJECTION 125433 001 2013-07-18   Start Trial Adventist Health System/Sunbelt Inc. (Altamonte Springs, FL) 2034-11-26 RX search
Centocor Ortho Biotech Inc SIMPONI golimumab INJECTABLE; INJECTION 125289 001 2009-04-24   Start Trial Adventist Health System/Sunbelt Inc. (Altamonte Springs, FL) 2034-11-26 RX Orphan search
Centocor Ortho Biotech Inc STELARA ustekinumab INJECTABLE; INJECTION 125261 002 2009-12-30   Start Trial Adventist Health System/Sunbelt Inc. (Altamonte Springs, FL) 2034-11-26 RX search
Centocor Ortho Biotech Inc STELARA ustekinumab INJECTABLE; INJECTION 125261 001 2009-12-30   Start Trial Adventist Health System/Sunbelt Inc. (Altamonte Springs, FL) 2034-11-26 RX search
Ucb Inc CIMZIA certolizumab pegol INJECTABLE; INJECTION 125160 001 2008-04-22   Start Trial Adventist Health System/Sunbelt Inc. (Altamonte Springs, FL) 2034-11-26 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial Adventist Health System/Sunbelt Inc. (Altamonte Springs, FL) 2034-11-26 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Merck
AstraZeneca
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.